Celon Pharma S.A. (WSE: CLN)
Poland
· Delayed Price · Currency is PLN 25.00
-0.30 (-1.19%)
Jan 21, 2025, 5:04 PM CET
Celon Pharma Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 18.51 | -28.12 | -39.28 | -11.61 | -0.92 | 11.94 | Upgrade
|
| Depreciation & Amortization | 49.44 | 48.95 | 42.43 | 39.38 | 29.59 | 20.62 | Upgrade
|
| Other Amortization | 1.64 | 1.06 | 1.67 | 1.96 | 2.18 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -17.98 | -10.95 | -3.48 | -0.13 | 0.32 | -0.68 | Upgrade
|
| Other Operating Activities | -52.43 | 11.86 | 2.56 | 0.28 | -2.95 | 0.17 | Upgrade
|
| Change in Accounts Receivable | -11.45 | -12.54 | -6.46 | 13.24 | 2.42 | -5.65 | Upgrade
|
| Change in Inventory | 2.28 | 11.98 | -15.01 | 6.38 | 0.3 | -6.46 | Upgrade
|
| Change in Other Net Operating Assets | -9.47 | -30.55 | 12.87 | -5.56 | 40.8 | -25 | Upgrade
|
| Operating Cash Flow | -17.18 | -8.31 | -4.7 | 43.95 | 71.74 | -5.05 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -38.73% | - | - | Upgrade
|
| Capital Expenditures | -15.64 | -32.81 | -33.91 | -41.35 | -99.48 | -64.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.88 | 1.24 | 0.59 | 0.17 | 0.63 | 0.81 | Upgrade
|
| Investment in Securities | 19.5 | 9.5 | - | -79.87 | 45.44 | -0.01 | Upgrade
|
| Other Investing Activities | -3.78 | 0.43 | 1.85 | - | 0.14 | -3.58 | Upgrade
|
| Investing Cash Flow | 0.39 | -21.64 | -31.47 | -121.05 | -53.27 | -67.74 | Upgrade
|
| Short-Term Debt Issued | - | 12.75 | - | - | 12.84 | - | Upgrade
|
| Total Debt Issued | 12.75 | 12.75 | - | - | 12.84 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -12.84 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -26.13 | -12.43 | -4.8 | -4.4 | -1.15 | Upgrade
|
| Total Debt Repaid | -26.68 | -26.13 | -12.43 | -17.64 | -4.4 | -1.15 | Upgrade
|
| Net Debt Issued (Repaid) | -13.93 | -13.37 | -12.43 | -17.64 | 8.44 | -1.15 | Upgrade
|
| Issuance of Common Stock | 40.51 | 0 | 0 | 216 | - | - | Upgrade
|
| Common Dividends Paid | -4.6 | -4.6 | -14.8 | -3.15 | -3.6 | -7.2 | Upgrade
|
| Other Financing Activities | -2.2 | -2.62 | -1.5 | -14.3 | -0.59 | -0.17 | Upgrade
|
| Financing Cash Flow | 19.79 | -20.59 | -28.72 | 180.91 | 4.25 | -8.52 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | 3 | -50.54 | -64.89 | 103.82 | 22.72 | -81.31 | Upgrade
|
| Free Cash Flow | -32.82 | -41.13 | -38.61 | 2.6 | -27.74 | -70 | Upgrade
|
| Free Cash Flow Margin | -15.66% | -19.23% | -19.91% | 1.33% | -17.62% | -68.46% | Upgrade
|
| Free Cash Flow Per Share | -0.62 | -0.81 | -0.76 | 0.06 | -0.62 | -1.56 | Upgrade
|
| Cash Interest Paid | 2.2 | 2.62 | 1.5 | 0.94 | 0.59 | 0.17 | Upgrade
|
| Cash Income Tax Paid | - | -0.97 | -0.52 | - | -1.28 | - | Upgrade
|
| Levered Free Cash Flow | 33.51 | -34.98 | -18.83 | -1.33 | 4.24 | -46.89 | Upgrade
|
| Unlevered Free Cash Flow | 34.98 | -33.32 | -17.79 | -0.36 | 4.66 | -46.78 | Upgrade
|
| Change in Net Working Capital | 16.41 | 32.8 | 4.6 | -6.09 | -74.93 | 6.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.